Alzamend Neuro Inc ALZN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/23/21 EDT
5.66quote price arrow down-0.07 (-1.22%)
Volume
322,342
Close
5.73quote price arrow down-0.01 (-0.17%)
Volume
17,464,815
52 week range
4.85 - 33.55

...

Loading . . .
  • Open8.14
  • Day High8.28
  • Day Low5.63
  • Prev Close5.73
  • 52 Week High33.55
  • 52 Week High Date06/15/21
  • 52 Week Low4.85
  • 52 Week Low Date07/19/21

Key Stats

  • Market Cap486.65M
  • Shares Out84.93M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open8.14
  • Day High8.28
  • Day Low5.63
  • Prev Close5.73
  • 52 Week High33.55
  • 52 Week High Date06/15/21
  • 52 Week Low4.85
  • 52 Week Low Date07/19/21
  • Market Cap486.65M
  • Shares Out84.93M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-110.40
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-4.991M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-27.52%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alzamend Neuro Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company focused on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The Company's pipeline consists of two therapeutic drug candidates: AL001 and AL002. The AL001 is a cocrystal technology delivering a therapeutic combination of lithium, proline and salicylate, known as AL001 or LiProSal, through two royalty-bearing worldwide licenses from the University of South...
Address
3802 Spectrum Blvd,, Suite C112c
Tampa, FL
33612
United States